NET LOSS PER SHARE (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of Basic And Diluted Net Loss Per Share

The following table sets forth the computation of basic and diluted net loss per share of common stock, Series A convertible preferred stock, and Series B convertible preferred stock (in thousands, except share and per share amounts):


	Year Ended December 31, 2025
	Series A Convertible Preferred Stock		Series B Convertible Preferred Stock		Common Stock

Numerator:
Allocation of net loss	$	(29,892)	$	(30,781)	$	(281,928)
Denominator:
Weighted-average shares outstanding	134,864		138,875		84,803,355
Net loss per share, basic and diluted	$	(221.65)	$	(221.65)	$	(3.32)


	Year Ended December 31, 2024
	Series A Convertible Preferred Stock		Series B Convertible Preferred Stock		Common Stock

Numerator:
Allocation of net loss	$	(31,718)	$	(29,671)	$	(208,560)
Denominator:
Weighted-average shares outstanding	154,856		144,862		67,885,831
Net loss per share, basic and diluted	$	(204.82)	$	(204.82)	$	(3.07)


	Year Ended December 31, 2023
	Series A Convertible Preferred Stock		Series B Convertible Preferred Stock		Common Stock

Numerator:
Allocation of net loss	$	(45,421)	$	(17,306)	$	(175,007)
Denominator:
Weighted-average shares outstanding	174,226		66,385		44,755,475
Net loss per share, basic and diluted	$	(260.70)	$	(260.69)	$	(3.91)

Schedule of Potentially Dilutive Securities

Potentially dilutive securities to the common stock include the following:


	December 31,
	2025	2024	2023
Series A convertible preferred stock, as converted to shares of common stock	8,991,383	8,991,383	11,495,724
Series B convertible preferred stock, as converted to shares of common stock	5,308,265	9,677,817	9,568,181
Options to purchase common stock	14,468,627	11,348,519	11,533,484
Warrants to purchase common stock	29,446	248,277	249,883
Restricted stock units	1,064,375	314,075	804,947
Total	29,862,096	30,580,071	33,652,219